Published in Cancer Weekly, May 15th, 2007
Since its acquisition by Actavis, Sindan has continued to experience strong growth. The business generated revenues of EUR95 million in 2006 and expectations for 2007 are for sales of EUR115 million.
Additional investment expected to build platform for future growth
Actavis is committed to extending its business in Romania and its capabilities...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.